Richard W. Paul & Associates »

Crispr Therapeutics shares owned by Richard W. Paul & Associates

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Richard W. Paul & Associates from 13F filings

Historical chart of Richard W. Paul & Associates investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Richard W. Paul & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Richard W. Paul & Associates

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.3k 42 54.00
2024-03-31 $2.9k 42 68.17
2023-12-31 $2.6k 42 62.60
2023-09-30 $1.9k 42 45.38
2023-06-30 $2.4k 42 56.14
2023-03-31 $1.9k 42 45.24
2022-12-31 $1.7k 42 40.64